BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 15741227)

  • 21. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Porto I; Van Gaal W; Banning A
    Eur Heart J; 2005 Oct; 26(20):2206; author reply 2206-7. PubMed ID: 16087650
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
    Coron Artery Dis; 2009 Jan; 20(1):9-14. PubMed ID: 19050596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
    Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
    Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations.
    Miller WL; Garratt KN; Burritt MF; Lennon RJ; Reeder GS; Jaffe AS
    Eur Heart J; 2006 May; 27(9):1061-9. PubMed ID: 16481332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of biochemical markers, 12-lead ECG and patient characteristics amongst patients calling for an ambulance due to a suspected acute coronary syndrome.
    Svensson L; Axelsson C; Nordlander R; Herlitz J
    J Intern Med; 2004 Apr; 255(4):469-77. PubMed ID: 15049881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
    Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: detection by cardiac troponins.
    Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):188-92. PubMed ID: 11387602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
    Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
    Chen WH; Lee PY; Ng W; Tse HF; Lau CP
    J Am Coll Cardiol; 2004 Mar; 43(6):1122-6. PubMed ID: 15028378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) Study.
    Menown IB; Mathew TP; Gracey HM; Nesbitt GS; Murray P; Young IS; Adgey AA;
    Am Heart J; 2003 Jun; 145(6):986-92. PubMed ID: 12796753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury.
    Gustavsson CG; Hansen O; Frennby B
    Scand Cardiovasc J; 2004 May; 38(2):75-9. PubMed ID: 15204231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
    Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.
    Briguori C; Colombo A; Airoldi F; Violante A; Focaccio A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Bonizzoni E; Ricciardelli B
    Eur Heart J; 2004 Oct; 25(20):1822-8. PubMed ID: 15474697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients.
    Vikenes K; Melberg T; Farstad M; Nordrehaug JE
    Scand Cardiovasc J; 2010 Apr; 44(2):69-75. PubMed ID: 19670037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Markers of myocardial ischemia in the evaluation of the effect of left anterior descending coronary artery lesion and collateral circulation on myocardial injury in 1-vessel off-pump coronary bypass surgery.
    Kirali K; Mansuroğlu D; Kayalar N; Güzelmeriç F; Alp M; Yakut C
    Heart Surg Forum; 2003; 6(3):143-8. PubMed ID: 12821428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes.
    Newby LK; Roe MT; Chen AY; Ohman EM; Christenson RH; Pollack CV; Hoekstra JW; Peacock WF; Harrington RA; Jesse RL; Gibler WB; Peterson ED;
    J Am Coll Cardiol; 2006 Jan; 47(2):312-8. PubMed ID: 16412853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic and prognostic significance of CK-MB, troponins, CRP, BNP and/or NT-proBNP in coronary angioplasty. Elevation mechanisms and clinical implications].
    Bertinchant JP; Ledermann B; Schmutz L; Pezzano M; Jamaleddin N; Cade S; Winum PF; Polge A
    Arch Mal Coeur Vaiss; 2007 Nov; 100(11):925-33. PubMed ID: 18209693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.